Repurposed bone drugs show promise in slowing deadly aortic bulges, indicating a novel treatment pathway linked to aging biology. A recent study highlights the connection between clonal hematopoiesis (CH) and aortic aneurysms, revealing that approximately 60% of patients with abdominal aortic aneurysms exhibit age-related blood cell mutations, which correlate with accelerated aneurysm growth. This research shifts the focus from the vascular system to the immune response, suggesting that mutations in blood stem cells can lead to detrimental changes in immune cell behavior within the aorta, particularly transforming macrophages into osteoclast-like cells that degrade arterial structure.

The findings underscore the significance of the RANK/RANKL signaling pathway, traditionally associated with bone remodeling, in vascular health. When this pathway is activated in the context of aneurysms, it promotes tissue breakdown rather than repair, leading to structural weaknesses in the aortic wall. Notably, interventions that inhibit this signaling, either genetically or pharmacologically, significantly slowed aneurysm progression in animal models. The study also explored the potential of existing osteoporosis drugs, such as anti-RANKL antibodies and alendronate, to mitigate aneurysm growth, leveraging their established safety profiles for potential clinical repurposing.

This research not only opens up new avenues for therapeutic strategies but also suggests a paradigm shift in the understanding of vascular diseases as interconnected with broader aging processes. By integrating biological signals from blood, such as those from clonal hematopoiesis, into current imaging practices, clinicians may better identify patients at risk for rapid aneurysm progression. This approach could lead to a more proactive model of vascular disease management, emphasizing prevention over reactive treatment, and highlighting the intricate relationships between aging systems rather than viewing them as isolated conditions.

Source: longevity.technology